Renhuan Xu | Chief Executive Officer
ARV Technologies

Renhuan Xu, Chief Executive Officer, ARV Technologies

ARV Technologies is a start-up biotechnology company focused on developing innovative vaccines to address critical unmet medical needs in areas such as infectious diseases and oncology.

Appearances:



WVIC/WAC Day 1 - Nov 29 @ 15:35

Preclinical evaluation of a low-dose universal SARS-CoV-2 mRNA vaccine

last published: 01/Dec/22 17:25 GMT

back to speakers

For conference programme and speaking opportunities:
Lauren Sheppard

lauren.sheppard@terrapinn.com

For sponsorship and exhibition opportunities:
Thomas Hall

thomas.hall@terrapinn.com